Promomed received the ASNA Award for an innovative drug for the treatment of COVID-19

The Russian Association of Independent Pharmacies (ASNA), which unites more than 10,000 pharmacies across the country, recognized Promomed as the winner in the "Innovation of the Year in the treatment of COVID-19" nomination for the development of the drug against coronavirus infection Areplivir.

The Association noted: "We really believe that the creation of Areplivir has fundamentally influenced the treatment regimens for coronavirus infection and saved thousands of lives."

The award was presented at the 11th ASNA Conference in Sochi.